Leo Pharma (Fucithalmic pharmaceutical product business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Leo Pharma (Fucithalmic pharmaceutical product business) General Information

Description

Developer of an ophthalmology drug. The company's Fucithalmic product is an ophthalmic gel containing fusidic acid for the topical treatment of bacterial conjunctivitis and other such eye infections.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Industriparken 55
  • 2750 Ballerup
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Amdipharm Mercury
Corporate Office
  • Industriparken 55
  • 2750 Ballerup
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leo Pharma (Fucithalmic pharmaceutical product business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Leo Pharma (Fucithalmic pharmaceutical product business)‘s full profile, request access.

Request a free trial

Leo Pharma (Fucithalmic pharmaceutical product business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Leo Pharma (Fucithalmic pharmaceutical product business)‘s full profile, request access.

Request a free trial

Leo Pharma (Fucithalmic pharmaceutical product business) FAQs

  • Where is Leo Pharma (Fucithalmic pharmaceutical product business) headquartered?

    Leo Pharma (Fucithalmic pharmaceutical product business) is headquartered in Ballerup, Denmark.

  • What industry is Leo Pharma (Fucithalmic pharmaceutical product business) in?

    Leo Pharma (Fucithalmic pharmaceutical product business)’s primary industry is Drug Discovery.

  • Is Leo Pharma (Fucithalmic pharmaceutical product business) a private or public company?

    Leo Pharma (Fucithalmic pharmaceutical product business) is a Private company.

  • What is Leo Pharma (Fucithalmic pharmaceutical product business)’s current revenue?

    The current revenue for Leo Pharma (Fucithalmic pharmaceutical product business) is 000000.

  • Who are Leo Pharma (Fucithalmic pharmaceutical product business)’s investors?

    LEO Pharma has invested in Leo Pharma (Fucithalmic pharmaceutical product business).

  • When was Leo Pharma (Fucithalmic pharmaceutical product business) acquired?

    Leo Pharma (Fucithalmic pharmaceutical product business) was acquired on 01-Apr-2013.

  • Who acquired Leo Pharma (Fucithalmic pharmaceutical product business)?

    Leo Pharma (Fucithalmic pharmaceutical product business) was acquired by Amdipharm Mercury.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »